CSTL – Castle Biosciences Inc.

CSTL — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

5.03

Margin Of Safety %

-29

Put/Call OI Ratio

0.22

EPS Next Q Diff

0.2

EPS Last/This Y

-0.56

EPS This/Next Y

0.45

Price

24.34

Target Price

43.56

Analyst Recom

1.11

Performance Q

3.36

Upside

-161.9%

Beta

0.96

Ticker: CSTL

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-06-02	CSTL	19.66	0.28	999.99	406
2026-06-03	CSTL	20.37	0.29	0.00	410
2026-06-04	CSTL	21.57	0.29	0.00	409
2026-06-05	CSTL	21.07	0.30	0.00	401
2026-06-08	CSTL	20.13	0.29	0.00	404
2026-06-09	CSTL	21.09	0.29	0.36	405
2026-06-10	CSTL	21.08	0.29	0.00	399
2026-06-11	CSTL	20.98	0.29	0.00	400
2026-06-12	CSTL	20.7	0.29	0.00	400
2026-06-15	CSTL	20.67	0.29	5.00	399
2026-06-16	CSTL	20.44	0.29	0.00	398
2026-06-17	CSTL	20.19	0.27	0.50	416
2026-06-18	CSTL	21.07	0.26	0.25	416
2026-06-22	CSTL	21.19	0.32	0.00	349
2026-06-23	CSTL	21.37	0.32	0.00	349
2026-06-24	CSTL	22.16	0.32	0.92	351
2026-06-25	CSTL	22.93	0.36	0.23	366
2026-06-26	CSTL	24.34	0.23	0.04	342
2026-06-29	CSTL	24.31	0.22	0.40	362
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-06-01	CSTL	20.93	-100.0	-33.6	-1.36
2026-06-02	CSTL	19.79	-100.0	-29.8	-1.36
2026-06-03	CSTL	20.39	-100.0	-37.1	-1.36
2026-06-04	CSTL	21.58	-100.0	-39.0	-1.36
2026-06-05	CSTL	21.07	-100.0	-32.2	-1.39
2026-06-08	CSTL	20.14	-100.0	-30.7	-1.39
2026-06-09	CSTL	21.06	-100.0	-38.0	-1.39
2026-06-10	CSTL	21.07	-100.0	-34.1	-1.39
2026-06-11	CSTL	20.98	-100.0	-33.8	-1.39
2026-06-12	CSTL	20.71	-100.0	-33.0	-1.39
2026-06-15	CSTL	20.64	-100.0	-33.8	-1.39
2026-06-16	CSTL	20.45	-100.0	-33.4	-1.39
2026-06-17	CSTL	20.18	-100.0	-33.1	-1.39
2026-06-18	CSTL	21.12	-100.0	-37.9	-1.39
2026-06-22	CSTL	21.22	-100.0	-34.7	-1.39
2026-06-23	CSTL	21.38	-100.0	-34.7	-1.39
2026-06-24	CSTL	22.16	-100.0	-37.1	-1.39
2026-06-25	CSTL	22.88	-100.0	-36.7	-1.39
2026-06-26	CSTL	24.31	-100.0	-38.7	-1.39
2026-06-29	CSTL	24.34	-100.0	-34.5	-1.39
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-06-02	CSTL	-23.59	-1.18	4.80
2026-06-03	CSTL	-23.59	-1.18	4.80
2026-06-04	CSTL	-24.29	-1.18	4.80
2026-06-05	CSTL	-24.10	-1.18	4.80
2026-06-08	CSTL	-24.10	-1.17	4.80
2026-06-09	CSTL	-24.01	-1.17	4.80
2026-06-10	CSTL	-24.07	-1.17	5.03
2026-06-11	CSTL	-24.07	-1.17	5.03
2026-06-12	CSTL	-24.07	-1.17	5.03
2026-06-15	CSTL	-24.07	-1.14	5.03
2026-06-16	CSTL	-22.79	-1.14	5.03
2026-06-17	CSTL	-22.79	-1.14	5.03
2026-06-18	CSTL	-20.65	-1.14	5.03
2026-06-22	CSTL	-20.11	-1.15	5.03
2026-06-23	CSTL	-20.11	-1.15	5.03
2026-06-24	CSTL	-20.36	-1.15	5.03
2026-06-25	CSTL	-20.36	-1.15	5.03
2026-06-26	CSTL	-20.36	-1.15	5.03
2026-06-29	CSTL	-20.36	-1.15	5.03
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

-0.49

Avg. EPS Est. Current Quarter

-0.4

Avg. EPS Est. Next Quarter

-0.29

Insider Transactions

-20.36

Institutional Transactions

-1.15

Beta

0.96

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

17.39

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

69.2

Max Drawdown 5-Year %

-85

Target Price

43.56

P/E

Forward P/E

PEG

P/S

2.17

P/B

1.6

P/Free Cash Flow

163.19

EPS

-0.43

Average EPS Est. Cur. Y

-1.39

EPS Next Y. (Est.)

-0.93

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-3.78

Relative Volume

0.74

Return on Equity vs Sector %

-30.4

Return on Equity vs Industry %

-13.6

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.21

EBIT Estimation

-34.5

◆ CSTL Healthcare

$24.32

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

14/20

Pullback

6/25

Volume

9/15

Valuation

12/20

TP/AR

2/10

Options

6/10

RSI

Range 1M

99.2%

Sup Dist

4.6%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

10/25

Growth

16/30

Estimates

2/20

Inst/Vol

2/15

Options

10/10

EPS Yr

-76.5%

EPS NY

36.3%

52W%

34.2%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟡 HOLD +14.5% upside

Quality

6/30

Valuation

6/30

Growth

11/25

Stability

8/10

LT Trend

2/5

Upside

+14.5%

Quality

MoS

-29%

CSTL — P/E HistoricalDiagnostics & Research

Castle Biosciences, Inc.

Sector: Healthcare

Industry: Diagnostics & Research

Employees: 942

Castle Biosciences, Inc., a molecular diagnostics company, provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), atopic dermatitis (AD), and uveal melanoma. The company offers DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test that predicts the likelihood of a positive sentinel lymph node and the risk of metastasis for patients with invasive cutaneous melanoma; TissueCypher, a risk stratification spatialomics test to predict future development of high-grade dysplasia and/or esophageal cancer in patients with non-dysplastic, indefinite dysplasia, and low-grade dysplasia BE; AdvanceAD-Tx, a non-invasive GEP test which is designed to guide systemic treatment selection for patients aged 12 years and older with moderateto-severe AD; DecisionDx-SCC, a GEP test for cutaneous squamous cell carcinoma; and MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions. It also provides DecisionDx-UM, a risk stratification GEP test that predicts the risk of metastasis for patients with uveal melanoma. The company offers its products to dermatology and gastroenterology markets. The company was incorporated in 2007 and is headquartered in Friendswood, Texas.

CSTL

Latest News

—

Caricamento notizie per CSTL…

stock quote shares CSTL – Castle Biosciences Inc. Stock Price stock today

news today CSTL – Castle Biosciences Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch CSTL – Castle Biosciences Inc. yahoo finance google finance

stock history CSTL – Castle Biosciences Inc. invest stock market

stock prices CSTL premarket after hours

ticker CSTL fair value insiders trading

CSTL – Castle Biosciences Inc.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: CSTL

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y